AICM is pleased to announce the appointment of Mr. Jeff Zhu, Cabot Executive Committee Member, President of Asia Pacific Region as the new Chairman of AICM effective as of March 23, 2018. Mr. Zhu replaces Dr. Alasdair Jelfs of Merck who received a new assignment from his company and decided to resign from his chairmanship of AICM.

Mr. Zhu has a profound experience in the regional and global chemical industry, especially in China. The Board firmly believes he will provide further impetus to the continued development of AICM with his strong leadership.

Furthermore,the Board appoints Mr. Ming C. Chien, CEO Greater China, LANXESS Chemical (China) Co., Ltd. as the new co-Deputy Chairman of AICM along with Mr. Paul Lindblad, President, Greater China, Wacker Chemicals (China) Co., Ltd. Mr. Chien replaces Mr. Jeff Zhu, who will take the position as the new AICM Chairman.

The Board, per the bylaws, appoints one new Director, namely, Mr. Xavier Durand-Delacre, Senior Vice-President, Asia Pacific President, Arkema China Investment Co., Ltd. effective March 23, 2018.

The Board would like to express its sincere appreciation for Dr. Jelfs remarkable contributions and leadership which have developed AICM into a renowned organization. We wish him great success in his new endeavors. With the new leaders in place, AICM reiterates our commitment that AICM will continue the relentless journey in promoting Responsible Care in China.

Bios - Mingcheng Chien.pdf

Bios-Jeff Zhu.pdf

Resume Xavier DURAND-DELACRE Arkema.pdf

AICM new Board Directors announcement 201803 final.pdf